A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index


About Vicuron

Vicuron Pharmaceuticals is an international biopharmaceutical company focused on discovering, developing, manufacturing and commercializing vital medicine for seriously ill patients. The company's lead products are in Phase III clinical trials and include anidulafungin, a novel antifungal agent, and dalbavancin, a novel intravenous antibiotic for the treatment of serious Gram-positive infections. Dalbavancin, is a next-generation antibiotic belonging to the same class as vancomycin, one of the most widely used injectable antibiotics for Staphylococcal infections.


Pipeline for Vicuron


Anidulafungin -- anti-fungal

Dalbavancin -- glycopeptide class of antibiotics (hospital infections)

Oxazolidinones -- most-difficult-to-treat, multi-drug-resistant bacteria

Deformylase Inhibitors --antibiotic -- respiratory tract infections


More on Vicuron


Home Page

Key Statistics for Vicuron

Basic Chart for Vicuron

Analyst Opinion

Analysts Estimates


Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.